DAHANCA19: A randomized phase III study of primary (chemo-) radiotherapy and zalutumumab in head and neck carcinomas

J. G. Eriksen; C. Maare; J. Johansen; H. Primdahl; J.  Evensen; C. A.  Kristensen; Lisbeth Juhler Andersen; J. Overgaard

DAHANCA19: A randomized phase III study of primary (chemo-) radiotherapy and zalutumumab in head and neck carcinomas

J. G. Eriksen, C. Maare, J. Johansen, H. Primdahl, J. Evensen, C. A. Kristensen, Lisbeth Juhler Andersen, J. Overgaard

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	OC-0372
Tidsskrift	Radiotherapy & Oncology
Vol/bind	111
Udgave nummer	Suppl. 1
Sider (fra-til)	154-155
ISSN	0167-8140
Status	Udgivet - 2014
Begivenhed	ESTRO, European Society for Radiotherapy & Oncology - Vienna, Østrig Varighed: 4 apr. 2014 → 8 apr. 2014 Konferencens nummer: 33 http://www.estro.org/congresses-meetings/items/estro-33

Konference

Konference	ESTRO, European Society for Radiotherapy & Oncology
Nummer	33
Land/Område	Østrig
By	Vienna
Periode	04/04/2014 → 08/04/2014
Internetadresse	http://www.estro.org/congresses-meetings/items/estro-33

Adgang til dokumentet

http://www.estro.org/congresses-meetings/articles/estro-33-scientific-programme

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Eriksen, J. G., Maare, C., Johansen, J., Primdahl, H., Evensen, J., Kristensen, C. A., Andersen, L. J., & Overgaard, J. (2014). DAHANCA19: A randomized phase III study of primary (chemo-) radiotherapy and zalutumumab in head and neck carcinomas. Radiotherapy & Oncology, 111(Suppl. 1), 154-155. Artikel OC-0372. http://www.estro.org/congresses-meetings/articles/estro-33-scientific-programme

@article{b304fb1ae65e40a493b63d01ce0eeb75,

title = "DAHANCA19: A randomized phase III study of primary (chemo-) radiotherapy and zalutumumab in head and neck carcinomas",

author = "Eriksen, {J. G.} and C. Maare and J. Johansen and H. Primdahl and J. Evensen and Kristensen, {C. A.} and Andersen, {Lisbeth Juhler} and J. Overgaard",

year = "2014",

language = "English",

volume = "111",

pages = "154--155",

journal = "Radiotherapy & Oncology",

issn = "0167-8140",

publisher = "Elsevier",

number = "Suppl. 1",

note = "ESTRO, European Society for Radiotherapy & Oncology ; Conference date: 04-04-2014 Through 08-04-2014",

url = "http://www.estro.org/congresses-meetings/items/estro-33",

}

Eriksen, JG, Maare, C, Johansen, J, Primdahl, H, Evensen, J, Kristensen, CA, Andersen, LJ & Overgaard, J 2014, 'DAHANCA19: A randomized phase III study of primary (chemo-) radiotherapy and zalutumumab in head and neck carcinomas', Radiotherapy & Oncology, bind 111, nr. Suppl. 1, OC-0372, s. 154-155. <http://www.estro.org/congresses-meetings/articles/estro-33-scientific-programme>

TY - ABST

T1 - DAHANCA19

T2 - ESTRO, European Society for Radiotherapy & Oncology

AU - Eriksen, J. G.

AU - Maare, C.

AU - Johansen, J.

AU - Primdahl, H.

AU - Evensen, J.

AU - Kristensen, C. A.

AU - Andersen, Lisbeth Juhler

AU - Overgaard, J.

N1 - Conference code: 33

PY - 2014

Y1 - 2014

M3 - Conference abstract in journal

SN - 0167-8140

VL - 111

SP - 154

EP - 155

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

IS - Suppl. 1

M1 - OC-0372

Y2 - 4 April 2014 through 8 April 2014

ER -